Point72 Asset Management
MESO

Point72 Asset Management’s Mesoblast MESO Stock Holding History

Point72 Asset Management’s Portfolio MESO Stock Details MESO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-38,185
Closed -$689K – 4206
2025
Q4 		$689K Buy
+38,185
New +$657K ﹤0.01% 3070
2025
Q2 		– Sell
-1,066
Closed -$13.3K – 2445
2025
Q1 		$13.3K Buy
+1,066
New +$17.6K ﹤0.01% 1976

Other funds holding MESO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
PM
Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Point72 Asset Management's MESO Position: Q1 2026 in Review

Point72 Asset Management sold out of Mesoblast (MESO) in Q1 2026, closing a stake of 38,185 shares — an estimated $689K sold.

Point72 Asset Management first reported a position in MESO in Q1 2025 and held it in 2 quarters. The position peaked at $689K in Q4 2025. 69 funds tracked by Wall St. Rank hold MESO as of Q1 2026.

  • Point72 Asset Management reported no remaining Mesoblast position as of Q1 2026 after selling out during the quarter.
  • Point72 Asset Management sold 38,185 Mesoblast shares in Q1 2026, an estimated $689K.
  • Point72 Asset Management first reported a position in Mesoblast in Q1 2025 and held it in 2 quarters.
  • Point72 Asset Management's Mesoblast position peaked at $689K in Q4 2025.
  • 69 funds tracked by Wall St. Rank held Mesoblast as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.